Showing 1751-1760 of 2192 results for "".
- Purple Day Is Coming on March 26, 2021 With Education and Advocacy to Destigmatize Epilepsyhttps://practicalneurology.com/news/purple-day-is-coming-on-march-26-2021-with-education-and-advocacy-to-destigmatize-epilepsy/2469531/Purple Day is coming soon on March 26th, 2021 epilepsy specialists, people living with epilepsy, and adv
- Update on Neurologic Post-Acute Sequelae of SARS-CoV-2 Infectionhttps://practicalneurology.com/news/update-on-neurologic-post-acute-sequelae-of-sars-cov-2-infection/2470167/The concept of “original antigenic sin” may play an i
- Physician Visits Increased Up to 15 Years Before MS Symptom Onsethttps://practicalneurology.com/news/physician-visits-increased-up-to-15-years-before-ms-symptom-onset/2476101/Results from a large, matched cohort study published in JAMA Network Open reveal that health care use begins to rise 14 to 15 years before the onset of the first recognized symptoms of multiple sclerosis (MS). The findings suggest a longer prodromal phase than previously understood, with
- Treatment of Focal Epilepsy with Cenobamate Associated with Lower Inpatient Days and ER Visits Compared with 7 Leading Anti-Seizure Medicationshttps://practicalneurology.com/news/treatment-of-focal-epilepsy-with-cenobamate-associated-with-lower-inpatient-days-and-er-visits-compared-with-7-leading-anti-seizure-medications/2470448/The addition of cenobamate to the treatment regimens of people with focal epilepsy was associated with lower rates of inpatient days and emergency room (ER) visits compared with the addition of 7 other leading anti-seizure medications (ASMs). This finding, which was presented at the American Acad
- Prescription Digital Therapeutic Reduced Insomnia Severity and Decreased Emergency Department Visitshttps://practicalneurology.com/news/prescription-digital-therapeutic-reduced-insomnia-severity-and-decreased-emergency-department-visits/2470000/In analysis of real-world data, prescription digital therapeutic (PDT) (Somryst; Pear Therapeutics, Boston, MA) showed clinically meaningful reductions in insomnia severity index (ISI) score after 9 weeks of. People who used the PDT also had reductions in health-related services and costs in the
- Study Suggests Key Topics to Discuss in Initial Alzheimer’s Diagnostic Visithttps://practicalneurology.com/news/study-suggests-key-topics-to-discuss-in-initial-alzheimers-diagnostic-visit/2468963/Research has identified 17 topics in 4 categories that people with Alzheimer’s disease (AD), their caregivers, and health care professionals feel are important to discuss, as well as the timing for the discussion topics (Table).
- Tiger Trial Shows Efficacy for New Class of Radially Adjustable Stentrievers in Acute Ischemic Strokehttps://practicalneurology.com/news/tiger-trial-shows-efficacy-for-new-class-of-radially-adjustable-stentrievers-in-acute-ischemic-stroke/2469537/Data from a prospective clinical trial (NCT03474549) showed treatment of acute ischemic stroke (AIS) due to large vessel occlusion (LVO) with a novel, radially adjustable stentriever (Tigertriever; Rapid Medical, Sunrise, FL) was super
- Fosgonimeton Well Tolerated With Possible Benefits for Alzheimer Disease in the Absence of Cholinergic Treatmenthttps://practicalneurology.com/news/fosgonimeton-well-tolerated-with-possible-benefits-for-alzheimer-disease-in-the-absence-of-cholinergic-treatment/2469991/In the phase 2 ACT-AD trial (NCT04491006), fosgonimeton (Athira Pharma, Bothell, WA) was well-tolerated, and no serious adverse events (AEs ) occurred. Mild-to-moderate AEs occurred in 89% (24/27) and 100% (26/26), respectively,
- AAN Issues Guideline on Vaccines for People With Multiple Sclerosishttps://practicalneurology.com/news/aan-issues-guideline-on-vaccines-for-people-with-multiple-sclerosis/2469002/In a guideline published in the current online issue of Neurology, the American Academy of Neurology (AAN) recommends that people with multiple sclerosis (MS) receive recommended vaccinations, including y
- Cases of Dementia Projected to Increase Worldwidehttps://practicalneurology.com/news/cases-of-dementia-projected-to-increase-worldwide/2469646/Data presented at the Alzheimer's Association International Congress July 26-30, 2021 show that all types of dementia have been on the rise in recent years and are predicted to increase further. Rates of early-onset dementia are also increasing, and in the US, mortality from Alzheimer diseae